Welcome back to Baby Breakerdom! This week's quest to find budding Rule Breakers reveals technology that could end hospital visits and venture capitalists that want your trash. (Really.)

First up this week is MicroCHIPS, a start-up creating a drug-delivery system that VentureWire says would need no human oversight. A quick check of the company website provides some explanation. The idea, it seems, is to implant biosensors and what the company calls "reservoir arrays" that would store medicine safely, releasing only what's needed, when it's needed. That, says MicroCHIPS, could eliminate the need for visits to the doctor to receive painful shots.

The story gets more interesting when you consider that on Wednesday, well-known medical device manufacturers Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT) were added to its roster of investors. At the very least, it provides a strong endorsement for the technology, and it may increase MicroCHIPS' chances of eventually going public.

Next, it's on to clean technology. What's that, you ask? In effect, it's any technology that reduces waste -- devices for solar and wind power would provide good examples. Those and similar technologies are taking off, and VCs want a piece of the action. Indeed, VentureWire reports that clean technology investing now accounts for 6% to 7% of all venture funding. Moreover, investments in the sector are expected to top $1.5 billion this year, up 50% from 2004, according to the CleanTech Venture Network.

In light of this, venture firm Draper Fisher Jurvetson Tuesday told VentureWire that it plans a $150 million clean technology affiliate fund called DJF Element. The plan seems timely given the momentum earned by upstarts such as Evergreen Solar (NASDAQ:ESLR) and Energy Conversion Devices (NASDAQ:ENER). Or, for that matter, the oil-slicked problems facing industrial giants such as Ford (NYSE:F) and AMR's (NYSE:AMR) American Airlines.

Sadly there were no Baby Breaker public offerings this week, which means it's time to say goodbye for now. See you back here next Friday when we continue the quest for the next ultimate growth stock.

For more Rule Breaking Foolishness:

Netflix. Marvel. AOL. Starbucks. Find out how David Gardner landed these and other multibaggers by taking a risk-free trial to Motley Fool Rule Breakers today. Your portfolio will thank you.

Fool contributor Tim Beyers has a hard enough time getting clean clothes, let alone clean technology. He thinks it's worth the effort, though. Tim didn't own stock in any of the companies mentioned in this story at the time of publication. You can find out what is in his portfolio by checking Tim's Fool profile. Overstock.com is a Motley Fool Rule Breakers pick. The Motley Fool has an ironclad disclosure policy.